Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svitlana Garbuzova-Davis

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Cellular Neuroscience|February 20, 2014
Blood-CNS Barrier Impairment in ALS patients versus an animal modelSvitlana Garbuzova-Davis, Paul R Sanberg
Stem Cell Reviews and Reports|June 24, 2023
Transplanted Human Bone Marrow Endothelial Progenitor Cells Prolong Functional Benefits and Extend Survival of ALS Mice Likely via Blood-Spinal Cord Barrier RepairSvitlana Garbuzova-Davis, Cesario V Borlongan
Frontiers in Aging Neuroscience|January 28, 2026
Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS miceSvitlana Garbuzova-Davis, Larai Manora, Cesario V Borlongan
Journal of Cellular and Molecular Medicine|October 19, 2018
Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseasesJared Ehrhart, Paul R Sanberg, Svitlana Garbuzova-Davis
Brain Circulation|June 4, 2021
Extracellular vesicle-based therapy for amyotrophic lateral sclerosisNadia Sadanandan, Jea-Young Lee, Svitlana Garbuzova-Davis
Expert Opinion on Biological Therapy|April 27, 2017
Cord blood as a potential therapeutic for amyotrophic lateral sclerosisSvitlana Garbuzova-Davis, Jared Ehrhart, Paul R Sanberg
Stem Cells Translational Medicine|October 1, 2022
Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral SclerosisMolly Monsour, Svitlana Garbuzova-Davis, Cesario V Borlongan
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Implications of blood-brain barrier disruption in ALSSvitlana Garbuzova-Davis, Samuel Saporta, Paul R Sanberg
Cells|March 13, 2024
Cellular and Noncellular Approaches for Repairing the Damaged Blood-CNS-Barrier in Amyotrophic Lateral SclerosisLarai Manora, Cesario V Borlongan, Svitlana Garbuzova-Davis
Eneuro|July 15, 2022
Apolipoprotein A1 Enhances Endothelial Cell Survival in an <i>In Vitro</i> Model of ALSSvitlana Garbuzova-Davis, Alison E Willing, Cesario V Borlongan
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Cellular Neuroscience|February 20, 2014
Blood-CNS Barrier Impairment in ALS patients versus an animal modelSvitlana Garbuzova-Davis, Paul R Sanberg
Stem Cell Reviews and Reports|June 24, 2023
Transplanted Human Bone Marrow Endothelial Progenitor Cells Prolong Functional Benefits and Extend Survival of ALS Mice Likely via Blood-Spinal Cord Barrier RepairSvitlana Garbuzova-Davis, Cesario V Borlongan
Frontiers in Aging Neuroscience|January 28, 2026
Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS miceSvitlana Garbuzova-Davis, Larai Manora, Cesario V Borlongan
Journal of Cellular and Molecular Medicine|October 19, 2018
Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseasesJared Ehrhart, Paul R Sanberg, Svitlana Garbuzova-Davis
Brain Circulation|June 4, 2021
Extracellular vesicle-based therapy for amyotrophic lateral sclerosisNadia Sadanandan, Jea-Young Lee, Svitlana Garbuzova-Davis
Expert Opinion on Biological Therapy|April 27, 2017
Cord blood as a potential therapeutic for amyotrophic lateral sclerosisSvitlana Garbuzova-Davis, Jared Ehrhart, Paul R Sanberg
Stem Cells Translational Medicine|October 1, 2022
Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral SclerosisMolly Monsour, Svitlana Garbuzova-Davis, Cesario V Borlongan
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Implications of blood-brain barrier disruption in ALSSvitlana Garbuzova-Davis, Samuel Saporta, Paul R Sanberg
Cells|March 13, 2024
Cellular and Noncellular Approaches for Repairing the Damaged Blood-CNS-Barrier in Amyotrophic Lateral SclerosisLarai Manora, Cesario V Borlongan, Svitlana Garbuzova-Davis
Eneuro|July 15, 2022
Apolipoprotein A1 Enhances Endothelial Cell Survival in an <i>In Vitro</i> Model of ALSSvitlana Garbuzova-Davis, Alison E Willing, Cesario V Borlongan
Pageof 7